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Abstract
Background: Albeit other prospective randomized controlled clinical trials on H-Wave Device
Stimulation (HWDS), this is the first randomized double-blind Placebo controlled prospective
study that assessed the effects of HWDS on range of motion and strength testing in patients who
underwent rotator cuff reconstruction.
Methods: Twenty-two patients were randomly assigned into one of two groups: 1) H-Wave
device stimulation (HWDS); 2) Sham-Placebo Device (PLACEBO). All groups received the same
postoperative dressing and the same device treatment instructions. Group I was given HWDS
which they were to utilize for one hour twice a day for 90 days postoperatively. Group II was given
the same instructions with a Placebo device (PLACEBO). Range of motion was assessed by using
one-way ANOVA with a Duncan Multiple Range Test for differences between the groups
preoperatively, 45 days postoperatively, and 90 days postoperatively by using an active/passive scale
for five basic ranges of motions: Forward Elevation, External Rotation (arm at side), External
Rotation (arm at 90 degrees abduction), Internal Rotation (arm at side), and Internal Rotation (arm
at 90 degrees abduction). The study also evaluated postoperative changes in strength by using the
Medical Research Council (MRC) grade assessed strength testing.
Results:  Patients who received HWDS compared to PLACEBO demonstrated, on average,
significantly improved range of motion. Results confirm a significant difference for external rotation
at 45 and 90 days postoperatively; active range at 45 days postoperatively (p = 0.007), active at 90
days postoperatively (p = 0.007). Internal rotation also demonstrated significant improvement
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compared to PLACEBO at 45 and 90 days postoperatively; active range at 45 days postoperatively
(p = 0.007), and active range at 90 days postoperatively (p = 0.006). There was no significant
difference between the two groups for strength testing.
Conclusion: HWDS compared to PLACEBO induces a significant increase in range of motion in
positive management of rotator cuff reconstruction, supporting other previous research on HWDS
and improvement in function. Interpretation of this preliminary investigation while suggestive of
significant increases in Range of Motion of Post -Operative Rotator Cuff Reconstruction, warrants
further confirmation in a larger double-blinded sham controlled randomized study.
Background
No matter age, race, physical ability or activity levels, rota-
tor cuff injuries are one of the most common causes of
shoulder pain. In the United States alone, over 6 million
people seek medical care each year for shoulder problems.
Finding reliable treatment for pain and its fundamental
causation, including pain reported by patients recovering
from post-surgical rotator cuff reconstruction, presents a
very real set of challenges.
History and Treatment Aspects
For those less familiar with the field we are providing a
brief statement relative to treatment options and out-
comes for informative purposes only. Almost 100 years
have past since the first report of rotator cuff repair in
1898 by W. Muller [1]. Today various solutions for diffi-
cult extended forms of rotator cuff lesions are available
besides the closed and semi-closed arthroscopic tech-
niques. It is inevitable in chronic degenerative tears with
muscle atrophy that there will be loss of function. The
treatment of massive rotator cuff tears must be adapted to
the patient's individual needs and preoperative parame-
ters to achieve the best outcome. Briefly, first the shoulder
surgeon has to determine whether a direct transosseous
repair is possible. If there is not enough remaining tissue,
the tissue is atrophic, and the tendon stump can be
reduced only with great tension, one can use a margin
convergence technique for partial closure, perform a
biceps tendoplasty, or perform local tendon transfers with
subscapularis or infraspinatus muscle. Moreover, if the
defect cannot be sufficiently closed, for example elderly
patients with low demands can be treated with tuber-
cleplasty/subacrominal decompression, whereas patients
younger than 60 years with higher demands should
receive muscle and tendon transfers. It is important that
every effort should be made to perform early anatomic
reconstruction in a young patients as well reduce pain as
the function of the rotator cuff is of significant importance
in the workforce. In younger patients for example, a bal-
anced posterosuperior defect can be reconstructed by a
deltoid muscle transfer, in contrast to an unbalanced one,
which is best treated with an active transfer of the latis-
simus dorsi muscle and tendon. Generally, anterior
defects can be addressed by pectorallis muscle transfer.
However, if the humeral head is superiorly migrated, if
signs of osteoarthritis are present, and if the patient is
older than 70 years, a reverse prosthesis can be implanted
as a salvage procedure. There have been many reviews per-
taining to both treatment and clinical outcomes including
management of isolated subscapularis tendon tears [2,3];
massive tears[4] and artroscopically assisted rotator cuff
repair [5-7] as well as arthroscopic rotator cuff repair with
double row fixation [8] Interestingly a prospective evalua-
tion of the effect of rotator cuff integrity on the outcome
of open cuff repairs found evidence to support open rota-
tor cuff repair as an effective technique that restores excel-
lent shoulder function[9].
Anatomy
The rotator cuff comprises of four small muscles and their
musculotendinous attachments, acting as the dynamic
stabilizer of the Glenohumeral joint. These muscles work
as a complex, rather than individually. Often people
injure one particular member of the rotator cuff, however
Rotator cuff anatomy, anterior Figure 1
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most injuries usually involve more than one muscle (Fig-
ures 1 and 2). The subscapularis muscle is innervated by
the subscapular nerve and originates on the scapula. It
internally rotates the humerus and inserts on the lesser
humeral tuberosity. The supraspinatus and infraspinatus
are both innervated by the suprascapular nerve, originate
in the scapula and insert on the greater tuberosity.
Supraspinatus abducts the humeral head and acts as a
humeral head depressor, while infraspinatus externally
rotates and horizontally extends the humerus. The teres
minor is innervated by the axillary nerve, originates on the
scapula and inserts on the greater tuberosity, externally
rotating and extending the humerus. The subacromial
space lies underneath the acromion, the coracoid process,
the acromioclavicular joint and the coracoacromial liga-
ment. A bursa in the subacromial space provides lubrica-
tion for the rotator cuff. Figure 1 and figure 2 show the
anterior and posterior rotator cuff anatomy, respectively.
The space between the undersurface of the acromion and
the superior aspect of the humeral head is called the
impingement interval. This space is normally narrow and
is maximally narrow when the arm is abducted. Any con-
dition that further narrows this space can cause impinge-
ment. Impingement can result from extrinsic compression
or from loss of competency of the rotator cuff. Pain from
any cause, such as overuse or injury, such as repetitive
overhead motions from sporting activities, work tasks or
daily chores, may lead to disuse or weakness of the cuff.
The weakness results in cephalad migration of the
humeral head due to loss of depressors.
Critical Issues: Chronic illness and pain medications
The anatomy and biomechanics of the shoulder always
guide the history and physical exam toward the appropri-
ate diagnosis and treatment of rotator cuff injuries. There
is still controversy over when Rotator Cuff surgery is rec-
ommended, According to Bytomski & Black [10] such,
surgical management is usually reserved for refractory
cases that have exhausted conservative measures, includ-
ing regimens of nonsteroidal anti-inflammatory drugs
(NSAIDs), corticosteroid injections, and functional reha-
bilitation therapy. In essence conservative measures are
usually carefully assessed by the attending physician Sev-
eral studies have documented high success rates following
the surgical treatment of full-thickness rotator cuff tears of
1-5 cm. However, as Van Linthoudt et al. [11] found, a
mean postsurgical symptom duration of 12 months
(range, 3-48 months) and a mean time to recovery of
shoulder power (75% of the value before the tear) as
assessed by patients of 10 months [11] can be daunting,
no matter the level of discomfort. Furthermore, only 25%
of the patients studied by Van Linthoudt that underwent
surgical treatment of full-thickness rotator cuff tears
exhibited improved range of motion six years post surgery
[11]. Historically, even less favorable and predictable
results have been found in the treatment of massive tears
(>5 cm) compared with small and medium sized tears;
determining the most appropriate treatment for a patient
with a massive rotator cuff tear can be challenging because
of inconsistent outcome results. However, according to
Jines and Savoie [12] more recent work using arthroscopic
repair even of large and massive cuff tears results in good
to excellent outcomes in 88% of patients. Moreover it is
well known that not all massive rotator cuff tears have
inconsistent outcome results. In fact, Kim et al. [13] con-
cluded in their study that Arthroscopic repair of medium
and large full - thickness rotator cuff tears had an equal
outcome to technically unsuccessful arthroscopic repairs,
which were salvaged by conversion to a mini -open tech-
nique. In fact, according to these researchers, surgical out-
come depended on the size of the tear, rather than the
method of repair.
Given the observed chronic nature of the recovery phase
in patients undergoing surgical rotator cuff repair, it is
important to note that chronic pain is consistently associ-
ated with disability and psychological distress [14]. In the
WHO study, chronic pain sufferers were significantly
more likely to experience marked limitations in activity
and to have an anxiety or depressive disorder compared
with patients without chronic pain [15]. In this regard, the
management of pain and recovery of lost function associ-
ated with post operative rotator cuff reconstruction pro-
vides a significant challenge to the orthopedic surgeon.
Interestingly, preoperative patient expectation of the out-
come for post operative rotator cuff reconstruction influ-
Rotator cuff anatomy, posterior Figure 2
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ences actual outcome. A rigorous multivariate analysis
controlling for age, gender, smoking, Workers' Compen-
sation status, symptom duration, number of previous
operations, number of comorbidities, tear size, and repair
technique confirmed that greater expectations were a sig-
nificant independent predictor of both better perform-
ance at one year and greater improvement on all measures
tested[16]. This observation, coupled with the known
chronic nature of postoperative recovery from rotator cuff
reconstruction, provided the impetus to develop a long
term treatment and hands on patient compliance pro-
gram through continual patient follow up and care. Thus
simple therapy alone with any treatment modality, phar-
macologically and or physical manipulation, must be
coupled with moderate to strong patient interaction.
Treatment of patients with chronic pain, as often observed
in rotator cuff injuries, usually involves prescription med-
ication such as opioids, an approach that may reduce pain
but that often fails to improve function, [17,18] and is
also associated with significant adverse consequences
such as opioid dependence, opioid-induced hyperalgesia,
cognitive dysfunction, and suppression of the immune
system [19-21]. Physical therapy and exercise programs
may alleviate some types of pain, although compliance is
often a problem [22-29]. There are 38,122 studies of pain
related to postoperative procedures in PUBMED. Moreo-
ver, there are 30 studies specifically related to pain and
rotator cuff reconstructive surgery.
H-Wave Device
During the past two decades, researchers have been
increasingly interested in the control of pain and restora-
tion of function through electrical stimulation. One area
of this research has focused on the H-Wave® (Electronic
Waveform Lab, Inc, Huntington Beach, CA, USA) device.
The purpose of the H-Wave device is to reduce or elimi-
nate chronic pain and inflammation. This goal may be
achieved via four mechanisms: firstly, through interstitial
fluid shifts produced at very low frequencies (1-2 Hz) by
direct stimulation of small-diameter skeletal muscle fibers
and smooth muscles of the lymphatic system. This stimu-
lation produces long rhythmical contractions of these spe-
cific muscle types, which can eliminate the accumulation
of proteins that are a source of inflammation: an impor-
tant component of pain and associated disability in
patients with trauma or chronic injury [30]. Secondly, the
H-Wave device also produces profound anaesthetic/anal-
gesic effects when utilized at high frequencies (60 Hz) by
affecting the function of the sodium pump within the
nerve [31]. Thirdly, recent animal research has shown that
stimulation of skeletal muscle by the H-Wave device pro-
duced a significant increase in the microcirculation, which
was nitric oxide-dependent [32]. Fourth, repetitive HWDS
to rodent hind limbs produced a profound and rapid
increase in blood flow as a function of observed angiogen-
esis [33,34]. These two factors obviates the possibility that
the repetitive HWDS reduces inflammation and promotes
quicker healing and better recovery due to the elimination
of protein build-up in post-operative conditions like rota-
tor cuff reconstruction.
Recently our laboratory performed a meta-analysis to sys-
tematically review the efficacy and safety of the H-Wave
device and program as a non-pharmacological analgesic
treatment in chronic soft tissue inflammation and neuro-
pathic pain. Five studies related to pain relief, reduction in
pain medication and increased function obtained with
the H-Wave device were included in the analysis. Data was
analyzed using the random effects model, including
adjustment to evaluate variability, size of study and bias
in effect size. A total of 6535 participants were included in
the meta-analysis [35-40]. The findings indicate a moder-
ate to strong effect of the H-Wave device in providing pain
relief, reducing the requirement for pain medication and
increasing function. The most robust effect was observed
for improved function, suggesting that the H-Wave device
may facilitate a quicker return to work and other related
daily activities [40].
Rationale for Pain Reduction
Pain may be undertreated, contributing to anguish, as
reported by the World Health Organization. Pain may
also be over treated, inadvertently contributing to drug
addiction, drug diversion, and even death. Thus, primum
non nocere--first, do no harm--is not easily achieved in the
pharmacological treatment of pain, particularly in pain
reported chronically. In 2008, Henn et al. [41] concluded
in a perspective study of 125 patients with Workers' Com-
pensation claims report worse outcomes, even after con-
trolling for confounding factors (1.e. age, work demands,
lower marital rates, education levels, preoperative expec-
tations) compared to non-workers' compensation
patients. Thus since the study by Henn et al. provides evi-
dence that the existence of a Workers' Compensation
claim portends a less robust outcome following rotator
cuff repair stimulated interest in evaluating H-Wave
Device Stimulation (HWDS)to improve outcome results.
Moreover even with today's ultra technical sophistication
according to Kasten et al. [42] surgery of the shoulder can
cause considerable pain. According to data from rand-
omized controlled trials, local or regional anaesthesia is
recommended for analgesia during and after surgery of
the upper extremity. This treatment involves potent addic-
tive opioids and non-steroidal anti-inflammatory drugs in
a multimodal analgesia approach. Additionally since the
pain is profound according to a meta-analysis of rand-
omized controlled trials, an interscalene block is recom-
mended for analgesia during and after surgery of the
shoulder. Other recommendations include physiotherapyBMC Musculoskeletal Disorders 2009, 10:132 http://www.biomedcentral.com/1471-2474/10/132
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postoperatively. Interestingly, while the use of arthro-
scopic procedures for most knee conditions yields rela-
tively mild and controlled pain, it is known that
arthroscopic procedures for rotator cuff repair and recon-
struction induces more significant pain for the patient
during the recovery phase, and hence remains a great chal-
lenge. The advent of pain pumps was initially met with
enthusiasm by many shoulder surgeons, but has led to
serious complications involving chodrolysis. In fact, sev-
eral studies which were confirmed by a bovine and rabbit
cartilage study suggested that there is significant chon-
drotoxicity from bupivacane, a local anesthetic com-
monly used in pain pumps [43].
With this in mind our laboratory, over last two decades,
has been searching for a non-pharmacologic alternative to
manage pain and restore lost function associated with
acute, subacute and chronic stages of various injuries and
conditions, as well as pain and lost function associated
with postoperative recovery and rehabilitation. The lim-
ited options for the management of soft tissue inflamma-
tion, neuropathic pain and in particular pain derived from
rotator cuff injuries have prompted the search for more
effective therapies; the following study is one example of
that arduous search.
Methods
Patient selection
All of the 22 patients had moderate to severe rotator cuff
injuries of various origin. All patients signed standard
approved IRB consent forms. This study received IRB
approval from the orthopedic clinic and a follow up
approval for the development of the actual write up the
PATH Research Foundation, New York, New York. The
registration number of the IRB NIH registration is #
(IRB00002334). In this study there were 9 males and 13
females.
Patient inclusion criteria
In the present investigation the following inclusion crite-
ria was developed which provided consistent eligibility
criteria for enrollment into the study:
1. The patients had a pre-diagnosis of rotator cuff
injury sufficient to require shoulder rotator cuff recon-
struction surgery.
2. The patient could be either male or female between
the ages of 18-75 years of age.
3. The patient is in satisfactory health as determined
by the investigator on the basis of medical history and
physical examination.
4. The patient provided a written informed consent
approved by the IRB prior to admission to the study.
Protocol
Albeit other prospective randomized controlled clinical
trials on repetitive HWDS, this is the first randomized
double-blind HWDS/Placebo controlled prospective
study executed at a well known orthopedic clinic and hos-
pital in Inglewood, California. The study assessed the
effects of HWDS on range of motion, and strength testing
in 22 patients who underwent rotator cuff reconstruction.
Each patient admitted into the study was assessed for both
range of motion by the pre-angles of ROM effects and
strength of testing. The purpose of this study was to deter-
mine differences between groups of patients who under-
went rotator cuff reconstruction: 1) H-Wave Electro
stimulation (Electronic Waveform Lab. Huntington
Beach, CA) [HWDS], and 2) Sham-Placebo device (PLA-
CEBO). Each group was instructed to use their device for
one hour twice a day, for 90 days; starting the day of sur-
gery. For this experiment the sham group was told not to
expect any sensation from the device (like a micro-current
device). All patients were randomly assigned by RW into
one of the two groups. The only individual knowledgea-
ble about which patient received either HWDS or PLA-
CEBO was the proctor RW. No other staff member of the
team knew the code or the results to avoid any bias. At the
end of the study the data was submitted to a staff member
for statistical evaluation. The blind procedure was pre-
served throughout the entire study. This was validated by
RW who interviewed each staff member to validate blind-
ing. Each patient was carefully fitted and instructed by RW
with HWDS and or PLACEBO. The patients were
instructed to use the device twice daily for one hour
throughout the 90 day experimental period. It is notewor-
thy that electrode placement for the H-Wave device was
inserted by the orthopedic surgeon around the surgery site
during the operative procedure. Thus, each patient had
their sterile pad placement carefully fitted by the attend-
ing orthopedic surgeon at the surgery site directly after the
operative sutures were in place and before the dressings
were applied. An H-Wave two channel (A & B) was used
as the testing device. Channel A electrode placement:
Superior pad was placed at the superior angle of the scap-
ula; overlapping the middle fibers of the Trapezius and
origin of the Supraspinatus muscle. Inferior pad was
placed just superior to the Deltoid Tuberosity on the
Humerus bone. Channel B electrode placement: Anterior
and posterior pads were placed at the beginning and end
of the suture line of the open reduction surgery. This
reduced stress relative to having to place the electro pads
every day for the first week. Every patient was visited again
on a two week basis and instructions were reviewed if
needed by RW with HWDS and or PLACEBO. If any prob-
lems arose while the patient was on the surgical floor of
the Hospital they were given a 24 hour phone number to
call if needed. It is noteworthy that there were no surgical
complications for any enrolled study member. Range of
motion was assessed for differences between the groupsBMC Musculoskeletal Disorders 2009, 10:132 http://www.biomedcentral.com/1471-2474/10/132
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preoperatively, 45 days postoperatively, and 90 days post-
operatively by using an active/passive scale for a number
of basic ranges of motions: Forward Elevation,  External
Rotation (arm at side), External Rotation (arm at 90 degrees
abduction), Internal Rotation (arm at side), and Internal
Rotation (arm at 90 degrees abduction). The study by also
using the Medical Research Council (MRC) grade assessed
strength testing. All of the patients in the study underwent
open Rotator Cuff repair and/or reconstruction. I n fact all
of the patients meeting inclusion criteria received major
open rotator cuff repair and or reconstruction rather than
arthroscopic procedure. None of the patients in the study
had pain pumps. It was important that there was conceal-
ment of group allocation to prevent group interaction and
potential bias. It is noteworthy that these patients were all
selected and enrolled by assessing suitability for the study
within a very short time frame (within days). However,
there was no pre-selection in terms of group entry. Thus
entry of a subject to a group was purely randomized. The
main inclusion criteria on the acceptance of surgical
patients was that the tear had to be large enough to justify
an open reduction surgery and not an Arthroscopic repair.
For this study the measurement of the tear and severity
were not considered as inclusion data per se.
Post-operative follow-up
All of the patients had the same post-operative follow-up
protocol and the operation and follow-up procedures
were all performed by the same surgeon to provide conti-
nuity of the study. In terms of post-operative rehabilita-
tion it is standard procedure that in post-operative rotator
cuff reconstruction patients are not allowed to lift the arm
and they are fitted for a sling for a long period of time. In
this study, no active Physical Therapy (PT) occurred in
most cases for at least 8 weeks post surgery. It was the pol-
icy of the attending physician that no active Physical ther-
apy was to be performed inside of 8 weeks post operative
period. After the 8 weeks Physical Therapy was encour-
aged and began. However each patient utilized the H-
Wave device and program or sham and were allowed only
passive Range of Motion (ROM). Moreover only the indi-
rect signs of recovery were measured. For this study RW
used Joint Range of Motion and Muscle strength. While
there was pre-diagnosis of the tear by MRI in general there
was no post MRI's performed. This was the decision of the
attending surgeon due to inconsistency of post MRIs. Fur-
thermore, the patient was asked to perform HWSD treat-
ments one hour twice daily for one month (active post
operative treatment-barely visible muscle contraction),
thereafter they were to reduce treatment to one treatment
for one hour every day for 2 months (active therapy-high
muscle contraction or to tolerance). It is noteworthy that
each patient had reporting sheets (Diary) to record their
treatments. This provided a means to determine compli-
ance.
Statistics
Differences between age at surgery, affected side, and gen-
der, were determined using a Chi-square test. Statistical
analysis of the range of motion preoperatively, 45 days
postoperatively, and 90 days postoperatively was deter-
mined by using an Active/Passive scale. The range of
motion of the involved extremity was compared to that of
the uninvolved extremity by using a One-Way ANOVA
with a Duncan Multiple Range Test. The MRC range scale
assessed strength testing between the groups. Statistical
analysis employed the statistical package SAS [44]. Careful
consideration as to the objectiveness of the measure for
ROM was taken into account prior to development of the
protocol for this study. The measurement used has been
validated in other studies, was familiar to the attending
physician and was objective.
Results
A total of 22 patients were studied following rotator
cuff surgery. 12 patients received an H-Wave Electro
Stimulation device (Group 1), and 10 patients received
a Placebo device (Group 2). There were no differences
between the groups in age, gender, or side of surgery.
There was no significant difference between the two
groups for strength testing; but generally, the 12
patients in Group 1 who received an active device
showed a non-significant higher strength level postop-
eratively. Group I patients showed on average a signifi-
cant amount of increased range of motion. A significant
difference was found for external rotation at 45 and 90
days postoperatively. At 45 days postoperative (PO)
Group 1 had a loss of 22.75 degrees (p = 0.0079) in
external rotation (arm at side), while Group 2 had a
loss of 33.00 degrees (p = 0.007) (see figure 3). At 90
days postoperative (PO) Group 1 had a loss of 11.67
degrees (p = 0.007) in external rotation (arm at side),
while Group 2 had a loss of 21.65 (p = 0.007). Group 1
also showed significant difference with internal rota-
tion (arm at 90 degrees) at 45 days postoperatively with
a loss of 23.75 degrees (p = 0.007), while Group 2 had
a loss of 33.00 degrees (p = 0.007). 90 days postopera-
tively Group I had a loss of 13.33 degrees (p = 0.006),
while Group 2 had a loss of 23.25 degrees (p = 0.0062)
(see figure 4). All other range of motions showed no
statistical difference.
It is noteworthy, after the initiation of Physical Therapy in
both active and non- active HWDS (post 8 weeks of sur-
gery) the patients that had active H-Wave advanced more
quickly on Physical Therapy as measured by ROM and
flexibility compared to the non -HWDS. Interestingly, fol-
lowing the approval of the attending physician, for the H-
Wave group a number of patients started Physical Therapy
at the 6 week time frame but this quicker Physical therapy
did not occur with the sham subjects.BMC Musculoskeletal Disorders 2009, 10:132 http://www.biomedcentral.com/1471-2474/10/132
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Discussion
Albeit the small sample size, statistical analysis has shown
that patients who have undergone rotator cuff reconstruc-
tion and used HWDS daily compared to PLACEBO
(SHAM) postoperatively, have benefited by increased
range of motion and possibly strength.
In physical medicine trials such as with the H-Wave
device, randomized, blinded, placebo controlled studies
are very difficult to produce and control in comparison
with other modalities and/or pharmaceutical trials [45].
Being cognizant of this fact, one of us (RW) carefully
developed a protocol that allowed for hands on blinded
controlled procedures. In each case and for every individ-
ual rigorous over site was systematically maintained
throughout the HWDS and PLACEBO periods. However,
despite these difficulties, the randomized double-blinded
Placebo controlled study herein presented on the H-Wave
device provides additional evidence that studies of this
nature can be successfully executed.
Additional studies, involving a much larger population,
are currently in progress and should provide additional
useful information. In future studies we expect that not
only range of motion would be significantly impacted but
so will strength, whereby we have already seen in the
present study a positive, but not a statistically-significant
trend.
The current significant results of daily repetitive long term
HWDS and program suggest an improved range of
motion and possibly strength post operatively. The mech-
anism of such a benefit may reside in the importance of
nitric oxide in cell communication and the inflammatory
process [46]. Wound healing impairment represents a par-
ticularly challenging clinical problem to which no effica-
cious treatment regimens currently exist. The factors
ensuing appropriate intercellular communication during
wound repair are not completely understood. Although
protein-type mediators are well- established players in the
process, emerging evidence from both animal and human
studies indicate that nitric oxide plays a key role in wound
repair. For example, nitric oxide elicits functional MMP-
13 protein-tyrosine nitration during wound repair [47].
The beneficial effects of nitric oxide on wound repair may
be attributed to its functional influences on angiogenesis
[48,34], inflammation, cell proliferation, matrix deposi-
tion, and remodeling [49].
The fact that animal research has shown that repetitive
HWDS induces significant angiogenesis compared to sin-
gle or intermittent HWDS suggest that this finding may
induce healing in tissue tears. Muscular contraction or
shear-wall stress is the best known factor for the intrinsic
production of angiogenesis. Interestingly, by stimulating
slow twitch myofibers, with associated mitochondria
activity, a larger and denser network of angiogenesis will
be formed. It is noteworthy, unlike other electrotherapeu-
tic devices which utilize fast twitch muscle fibers (e.g.
TENS, EMS, Hi-Volt Galvanic, interferential), H-Wave
therapy is known to utilize these slow twitch muscle fibers
in a non-fatiguing contraction [31].
A limitation in the present study is that the number of
patients evaluated, although significantly different, is
small and thus cautious interpretation may be suggested
45 and 90 day data showing the comparative changes  (improvements) in Post Operative loss of motion (in  degrees) for External Rotation (ER) of the afflicted arm/ shoulder between Group 1 (45 days: p = 0.007; 90 days: p =  0.007) and Group 2 (45 days: p = 0.007; 90 days: p = 0.007) Figure 3
45 and 90 day data showing the comparative changes 
(improvements) in Post Operative loss of motion (in 
degrees) for External Rotation (ER) of the afflicted 
arm/shoulder between Group 1 (45 days: p = 0.007; 
90 days: p = 0.007) and Group 2 (45 days: p = 0.007; 
90 days: p = 0.007).
45 and 90 day data showing the comparative changes  (improvements) in Post Operative loss of motion (in  degrees) for Internal Rotation (IR) of the afflicted arm/shoul- der between Group 1 (45 days: p = 0.007; 90 days: p = 0.006)  and Group 2 (45 days: p = 0.007; 90 days: p = 0.006) Figure 4
45 and 90 day data showing the comparative changes 
(improvements) in Post Operative loss of motion (in 
degrees) for Internal Rotation (IR) of the afflicted 
arm/shoulder between Group 1 (45 days: p = 0.007; 
90 days: p = 0.006) and Group 2 (45 days: p = 0.007; 
90 days: p = 0.006).BMC Musculoskeletal Disorders 2009, 10:132 http://www.biomedcentral.com/1471-2474/10/132
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until the data can be confirmed in a larger similar study.
Moreover, appropriate stratification was difficult to
achieve because of the small number of patients. While
size of the tear was assessed as well as pre-operative meas-
urement of range of motion the groups were randomized
rather than preselected. On one hand this allows for a bet-
ter double-blinded study but on the other hand it does
not control for appropriate stratification. Another concern
due to a small population is that rotator cuff injuries are
not clearly defined and classified with respect to localiza-
tion, size and chronic/acute tears. Indeed we are cognizant
that large subscapularis tears for example will have a dif-
ferent outcome in postoperative range of motion than
supaspinatus tears. It is noteworthy that although the
actual percentage of individuals that complied with the
treatment request was not adequately measured in the
sham group it is of importance that 100% of individuals
in the HWDS group utilized their device until the end of
the study (compliance in this group was accessed to be
85%). This is compared to a 40% return of the H-Wave
device from the sham group during the last 30 days of the
study days (P = 0.029) using a Fisher exact test. We are
cognizant that while there are no published studies to our
knowledge that have reported 100% of all rotator cuffs
had healed our results only support indirect measure-
ments to access function not overall repair. While the
funding for this study was d erived from a source that
would benefit financially from results, it is imperative to
realize that no one in the executive level provided signifi-
cant input to the outcome results of the study. With that
said one could still argue potential bias albeit the real like-
lihood of such bias.
Shoulder surgeries notoriously have tremendous issues
with pain in the first few weeks. Almost none of the active
H-Wave patients used pain medication while in the hos-
pital during their treatment. While the study didn't
directly assess pain, the improvement of ROM certainly
suggests that the H-Wave device and program had signifi-
cant pain relieving effects in these patients. However we
cannot draw a definitive conclusion concerning pain relief
from the present study. Additional work in this regard is
warranted.
Moreover, frozen shoulders are a major problem, in post
operative follow-up. It has been regarded by some as an
enigma, so catching the range of motion early is very val-
uable [50]. This is the reason why we set up H-Wave and
Sham in the recovery room. Based on our earlier research
on microcirculation in rats [34], we are confident that uti-
lization of the H-Wave device early on induced fluid
shifts, increased blood flow dependent on NO and poten-
tially initiated the angiogenesis process. Moreover it is
well known that inactivity of the shoulder in some will
result in soft tissue fibrosis and joint contracture follow-
ing anterior acromioplasty and/or rotator cuff repair. The
rehabilitation process is usually delayed for up to four to
six weeks to allow for healing [51]. There have been rec-
ommendations that following surgery of the shoulder that
active -assisted shoulder motion should be encouraged
immediately. In our study, while Physical Therapy was
not allowed for most patients to begin until 8 weeks post
surgery, it was noted that the patients receiving HWDS
compared HWDSHAM, began to move in a micro-way
earlier under the sling. It is hereby conjectured not proven
that this phenomena may have been due to the physiolog-
ical proven effects of the H-Wave device. Thus, in terms of
augmenting the healing process by virtue of increased
NO-dependent microcirculation and angiogenesis follow-
ing chronic HWDS treatment these benefits improved
outcome [31-34]. Certainly, this warrants more extensive
investigation.
These findings in this preliminary investigation suggest
but do not mandate that HWDS compared to PLACEBO
induces a significant and robust increase in range of
motion in postoperative management of rotator cuff
Reconstruction. Thus, using the H-Wave device if con-
firmed in a larger study, can be beneficial for the manage-
ment of post operative rotator cuff Reconstruction in
terms of significantly increasing their range of motion,
function and possibly strength, which will ultimately lead
to a faster healthier recovery.
Conclusion
Given any bias and or limitations described herein, con-
firmation of these results in a larger randomized double-
blind sham controlled study will provide impetus to uti-
lize HWDS as a frontline analgesic alternative increasing
function and achieving better recovery outcomes.
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